| Primary |
| Chronic Myeloid Leukaemia |
59.4% |
| Gastrointestinal Stromal Tumour |
17.6% |
| Acute Lymphocytic Leukaemia |
6.1% |
| Hypertension |
3.9% |
| Gastric Cancer |
1.8% |
| Pain |
1.1% |
| Malignant Soft Tissue Neoplasm |
1.0% |
| Neoplasm Malignant |
1.0% |
| Diabetes Mellitus |
0.9% |
| Prophylaxis |
0.9% |
| Pulmonary Arterial Hypertension |
0.8% |
| Leukaemia |
0.8% |
| Acute Myeloid Leukaemia |
0.7% |
| Nausea |
0.7% |
| Oedema |
0.7% |
| Constipation |
0.6% |
| Gastritis |
0.5% |
| Depression |
0.5% |
| Atrial Fibrillation |
0.5% |
| Glioblastoma Multiforme |
0.5% |
|
| Death |
51.2% |
| Vomiting |
7.0% |
| White Blood Cell Count Decreased |
4.3% |
| Neoplasm Malignant |
3.8% |
| Rash |
3.2% |
| Surgery |
3.1% |
| Nausea |
3.0% |
| White Blood Cell Count Increased |
2.8% |
| Weight Increased |
2.8% |
| Pneumonia |
2.3% |
| Weight Decreased |
2.1% |
| Pyrexia |
2.1% |
| Thrombocytopenia |
2.1% |
| Pleural Effusion |
1.7% |
| Diarrhoea |
1.6% |
| Drug Ineffective |
1.5% |
| Oedema Peripheral |
1.4% |
| Malignant Neoplasm Progression |
1.4% |
| Sepsis |
1.4% |
| Chronic Myeloid Leukaemia |
1.3% |
|
| Secondary |
| Chronic Myeloid Leukaemia |
46.9% |
| Gastrointestinal Stromal Tumour |
16.7% |
| Hypertension |
7.1% |
| Acute Lymphocytic Leukaemia |
5.8% |
| Prophylaxis |
3.0% |
| Gastritis |
2.3% |
| Dyspepsia |
1.9% |
| Pain |
1.6% |
| Gastric Ulcer |
1.6% |
| Atrial Fibrillation |
1.5% |
| Osteoporosis |
1.5% |
| Insomnia |
1.5% |
| Constipation |
1.4% |
| Oedema |
1.3% |
| Hypothyroidism |
1.2% |
| Gastric Cancer |
1.1% |
| Diabetes Mellitus |
1.0% |
| Nausea |
0.9% |
| Neoplasm Malignant |
0.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.9% |
|
| White Blood Cell Count Decreased |
18.1% |
| Vomiting |
14.3% |
| Death |
12.7% |
| White Blood Cell Count Increased |
7.8% |
| Weight Decreased |
5.8% |
| Rash |
5.5% |
| Pyrexia |
5.3% |
| Weight Increased |
4.2% |
| Thrombocytopenia |
3.7% |
| Nausea |
3.3% |
| Surgery |
2.7% |
| Diarrhoea |
2.6% |
| Neoplasm Malignant |
2.1% |
| Pancytopenia |
1.9% |
| Platelet Count Decreased |
1.8% |
| Pleural Effusion |
1.8% |
| Red Blood Cell Count Decreased |
1.8% |
| Swelling |
1.8% |
| Somnolence |
1.7% |
| Stomatitis |
1.5% |
|
| Concomitant |
| Chronic Myeloid Leukaemia |
34.4% |
| Drug Use For Unknown Indication |
16.7% |
| Product Used For Unknown Indication |
9.4% |
| Prophylaxis |
6.1% |
| Gastrointestinal Stromal Tumour |
5.4% |
| Pain |
2.5% |
| Hypertension |
2.4% |
| Multiple Myeloma |
2.4% |
| Pneumonia |
2.2% |
| Pulmonary Hypertension |
2.1% |
| Stent Placement |
2.0% |
| Leukaemia |
1.8% |
| Pulmonary Arterial Hypertension |
1.8% |
| Acute Lymphocytic Leukaemia |
1.6% |
| Neoplasm Malignant |
1.6% |
| Type 2 Diabetes Mellitus |
1.5% |
| Atrial Fibrillation |
1.4% |
| Mastocytosis |
1.4% |
| Nausea |
1.4% |
| Osteoporosis |
1.4% |
|
| White Blood Cell Count Decreased |
13.4% |
| Vomiting |
11.7% |
| Weight Decreased |
10.8% |
| Thoracic Cavity Drainage |
10.4% |
| Death |
6.1% |
| Pyrexia |
5.2% |
| Syncope |
5.2% |
| Thrombocytopenia |
4.8% |
| White Blood Cell Count Increased |
4.3% |
| Platelet Count Decreased |
3.0% |
| Rash |
3.0% |
| Drug Ineffective |
2.6% |
| Malaise |
2.6% |
| Pain |
2.6% |
| Pain In Extremity |
2.6% |
| Reversible Posterior Leukoencephalopathy Syndrome |
2.6% |
| Vision Blurred |
2.6% |
| Angina Pectoris |
2.2% |
| Fall |
2.2% |
| Pregnancy |
2.2% |
|
| Interacting |
| Schizophrenia |
35.4% |
| Acute Lymphocytic Leukaemia |
18.9% |
| Neuralgia |
13.0% |
| Chronic Myeloid Leukaemia |
8.4% |
| Anxiety Disorder |
4.0% |
| Gastrointestinal Stromal Tumour |
4.0% |
| Pulmonary Arterial Hypertension |
1.9% |
| Hypertension |
1.6% |
| Anxiety |
1.2% |
| Back Pain |
1.2% |
| Eosinophilic Leukaemia |
1.2% |
| Gastrointestinal Pain |
1.2% |
| Liver Transplant |
1.2% |
| Malignant Soft Tissue Neoplasm |
0.9% |
| Muscle Spasms |
0.9% |
| Nausea |
0.9% |
| Neoplasm Malignant |
0.9% |
| Pain In Extremity |
0.9% |
| Prophylaxis |
0.9% |
| Tuberculosis |
0.9% |
|
| Drug Interaction |
12.4% |
| Neuropathy Peripheral |
11.4% |
| Neoplasm Malignant |
7.6% |
| Cough |
6.7% |
| Drug Level Increased |
6.7% |
| Hypoaesthesia |
6.7% |
| Neoplasm Progression |
6.7% |
| Tremor |
5.7% |
| Visual Impairment |
5.7% |
| Vomiting |
4.8% |
| Weight Decreased |
4.8% |
| Immunosuppressant Drug Level Decreased |
3.8% |
| Interstitial Lung Disease |
2.9% |
| Pancytopenia |
2.9% |
| Peritoneal Lesion |
1.9% |
| Retinal Haemorrhage |
1.9% |
| Temporal Lobe Epilepsy |
1.9% |
| Thrombocytopenia |
1.9% |
| Tumour Lysis Syndrome |
1.9% |
| Urticaria |
1.9% |
|
